JPWO2023120643A1 - - Google Patents
Info
- Publication number
- JPWO2023120643A1 JPWO2023120643A1 JP2023569535A JP2023569535A JPWO2023120643A1 JP WO2023120643 A1 JPWO2023120643 A1 JP WO2023120643A1 JP 2023569535 A JP2023569535 A JP 2023569535A JP 2023569535 A JP2023569535 A JP 2023569535A JP WO2023120643 A1 JPWO2023120643 A1 JP WO2023120643A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021209975 | 2021-12-23 | ||
| PCT/JP2022/047366 WO2023120643A1 (ja) | 2021-12-23 | 2022-12-22 | Cxcr3発現細胞遊走活性が増強したcxcr3リガンド。 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023120643A1 true JPWO2023120643A1 (cg-RX-API-DMAC7.html) | 2023-06-29 |
| JPWO2023120643A5 JPWO2023120643A5 (cg-RX-API-DMAC7.html) | 2025-11-28 |
Family
ID=86902738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023569535A Pending JPWO2023120643A1 (cg-RX-API-DMAC7.html) | 2021-12-23 | 2022-12-22 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250073307A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4455158A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2023120643A1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN118660904A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023120643A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3892330A4 (en) | 2018-12-04 | 2022-10-26 | Chugai Seiyaku Kabushiki Kaisha | CXCR3 LIGAND |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003082335A1 (fr) * | 2002-04-03 | 2003-10-09 | Sumitomo Pharmaceuticals Co., Ltd. | Nouveau dispositif de controle du sucre dans le sang et procede de criblage associe |
| JP2008545396A (ja) * | 2005-05-18 | 2008-12-18 | インターミューン インコーポレイテッド | 非天然ケモカイン受容体リガンドおよびこれらの使用方法 |
| WO2020116498A1 (ja) * | 2018-12-04 | 2020-06-11 | 中外製薬株式会社 | Cxcr3リガンド |
| WO2021038033A1 (en) * | 2019-08-29 | 2021-03-04 | Antagonis Biotherapeutics Gmbh | T-cell mobilizing cxcl10 mutant with increased glycosaminoglycan binding affinity |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017364818C1 (en) | 2016-11-28 | 2025-05-15 | Chugai Seiyaku Kabushiki Kaisha | Ligand-binding molecule having adjustable ligand binding activity |
| KR20200089312A (ko) | 2017-11-28 | 2020-07-24 | 추가이 세이야쿠 가부시키가이샤 | 리간드 결합 활성을 조정 가능한 리간드 결합 분자 |
| KR20250134208A (ko) | 2017-11-28 | 2025-09-09 | 추가이 세이야쿠 가부시키가이샤 | 항원 결합 도메인 및 운반 부분을 포함하는 폴리펩티드 |
-
2022
- 2022-12-22 WO PCT/JP2022/047366 patent/WO2023120643A1/ja not_active Ceased
- 2022-12-22 EP EP22911345.1A patent/EP4455158A4/en active Pending
- 2022-12-22 CN CN202280091299.9A patent/CN118660904A/zh active Pending
- 2022-12-22 JP JP2023569535A patent/JPWO2023120643A1/ja active Pending
- 2022-12-22 US US18/722,266 patent/US20250073307A1/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003082335A1 (fr) * | 2002-04-03 | 2003-10-09 | Sumitomo Pharmaceuticals Co., Ltd. | Nouveau dispositif de controle du sucre dans le sang et procede de criblage associe |
| JP2008545396A (ja) * | 2005-05-18 | 2008-12-18 | インターミューン インコーポレイテッド | 非天然ケモカイン受容体リガンドおよびこれらの使用方法 |
| WO2020116498A1 (ja) * | 2018-12-04 | 2020-06-11 | 中外製薬株式会社 | Cxcr3リガンド |
| WO2021038033A1 (en) * | 2019-08-29 | 2021-03-04 | Antagonis Biotherapeutics Gmbh | T-cell mobilizing cxcl10 mutant with increased glycosaminoglycan binding affinity |
Non-Patent Citations (2)
| Title |
|---|
| CAMPANELLA, G.S.V., ET AL.: ""CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10)."", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 278, no. 19, JPN6023009611, 9 May 2003 (2003-05-09), pages 17066 - 17074, ISSN: 0005907492 * |
| GERLZA, T., ET AL.: ""Designing an improved T-cell mobilising CXCL10 mutant through enhanced GAG binding affinity."", PROTEIN ENGINEERING, DESIGN AND SELECTION, vol. 32, no. 8, JPN7023000972, 23 January 2020 (2020-01-23), pages 367 - 373, ISSN: 0005907491 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023120643A1 (ja) | 2023-06-29 |
| EP4455158A1 (en) | 2024-10-30 |
| EP4455158A4 (en) | 2026-04-15 |
| CN118660904A (zh) | 2024-09-17 |
| US20250073307A1 (en) | 2025-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR102022018833B1 (pt) | Método para monitorar um catalisador de oxidação, sistema para monitorar um catalisador de oxidação e sistema para monitorar um catalisador de oxidação para um motor de combustão interna de queima pobre | |
| CN306623117S (zh) | 吸顶灯(现代-双环) | |
| CN306623668S (zh) | 内衣(2152) | |
| CN306624267S (zh) | 笔套(京师二代) | |
| CN306624237S (zh) | 抽屉盒 | |
| CN306623363S (zh) | 脚皮刨刀(21023) | |
| CN306636282S (zh) | 茶具包装盒(1) | |
| CN306636065S (zh) | 瓶子(5l) | |
| CN306636279S (zh) | 面膜包装盒(葡萄酒) | |
| CN306610179S (zh) | 泵头(3) | |
| CN306612292S (zh) | 智能搜救信标 | |
| CN306597390S (zh) | 投影镜头固定座 | |
| CN306580438S (zh) | 文档拍摄仪(CZUR Lens) | |
| CN306594569S (zh) | 茶水桶(yh-007-1) | |
| CN306593198S (zh) | 茶水桶 | |
| CN306593989S (zh) | 包装盒(冻龙虾) | |
| CN306172668S (zh) | 茶漏 | |
| CN306173735S (zh) | 垃圾箱(集装箱创意小号) | |
| CN306131210S (zh) | 游戏套装(玩具) | |
| CN306156987S (zh) | 平衡车训练场覆盖层(夺旗竞速赛) | |
| CN306184657S (zh) | 按摩器(颈挂式) | |
| CN306156775S (zh) | 消毒柜 | |
| CN306174466S (zh) | 工程船 | |
| CN306157052S (zh) | 车路协同多功能信息杆柱(淀波) | |
| CN306172629S (zh) | 拾取和推动食物的手动叉 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251118 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251118 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20260706 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260713 |